551 related articles for article (PubMed ID: 11779500)
1. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
[TBL] [Abstract][Full Text] [Related]
2. Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene.
Shankaranarayanan P; Chaitidis P; Kühn H; Nigam S
J Biol Chem; 2001 Nov; 276(46):42753-60. PubMed ID: 11509556
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.
Espinosa JM; Emerson BM
Mol Cell; 2001 Jul; 8(1):57-69. PubMed ID: 11511360
[TBL] [Abstract][Full Text] [Related]
4. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
5. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
6. Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation.
Shan B; Xu J; Zhuo Y; Morris CA; Morris GF
J Biol Chem; 2003 Nov; 278(45):44009-17. PubMed ID: 12947108
[TBL] [Abstract][Full Text] [Related]
7. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression.
Qiu P; Li L
Circ Res; 2002 May; 90(8):858-65. PubMed ID: 11988486
[TBL] [Abstract][Full Text] [Related]
8. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
[TBL] [Abstract][Full Text] [Related]
9. DNA damage activates p53 through a phosphorylation-acetylation cascade.
Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
[TBL] [Abstract][Full Text] [Related]
10. Tat-controlled protein acetylation.
Col E; Gilquin B; Caron C; Khochbin S
J Biol Chem; 2002 Oct; 277(40):37955-60. PubMed ID: 12154097
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
13. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.
Chang LK; Liu ST
Nucleic Acids Res; 2000 Oct; 28(20):3918-25. PubMed ID: 11024171
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
[TBL] [Abstract][Full Text] [Related]
15. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.
Balasubramanyam K; Varier RA; Altaf M; Swaminathan V; Siddappa NB; Ranga U; Kundu TK
J Biol Chem; 2004 Dec; 279(49):51163-71. PubMed ID: 15383533
[TBL] [Abstract][Full Text] [Related]
16. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
[TBL] [Abstract][Full Text] [Related]
17. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins.
Soutoglou E; Papafotiou G; Katrakili N; Talianidis I
J Biol Chem; 2000 Apr; 275(17):12515-20. PubMed ID: 10777539
[TBL] [Abstract][Full Text] [Related]
19. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity.
Ray S; Sherman CT; Lu M; Brasier AR
Mol Endocrinol; 2002 Apr; 16(4):824-36. PubMed ID: 11923478
[TBL] [Abstract][Full Text] [Related]
20. HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.
Hsu CH; Chang MD; Tai KY; Yang YT; Wang PS; Chen CJ; Wang YH; Lee SC; Wu CW; Juan LJ
EMBO J; 2004 Jun; 23(11):2269-80. PubMed ID: 15141169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
